Cost Transparency — Avoiding Surprise Bills
Cost transparency is one of the most overlooked factors in the Clinic Selection & Success Rates pathway. This article breaks down how pricing clarity—not just clinic quality—affects your outcomes, budget, and timeline. When costs are predictable, decisions become calmer, cycles run smoother, and you avoid sudden expenses that derail care. What It Is Cost Transparency […]
Hospital Selection — NICU and Maternity Standards
This article explains hospital selection — NICU and maternity standards within the International Surrogacy & Cross-Border Care pathway. It focuses on the choices that actually change outcomes, budgets, and timelines—so you can move forward with confidence. What It Is Hospital Selection — NICU and Maternity Standards in plain English: understanding how to choose the right […]
High Responders — OHSS Prevention Playbook
This article explains high responders — OHSS prevention playbook within the IVF Protocols & Medications pathway. It highlights the choices that meaningfully affect outcomes, safety, budgets, and timelines—so you can move forward with confidence and control. What It Is High responders are people who grow more follicles than average during IVF stimulation. While this may […]
Prioritizing Embryos — PGT vs Morphology
When you have more than one embryo ready for transfer, you must decide which embryo goes first. Two major tools guide this decision: PGT (genetic information): chromosomal normality, mosaicism, translocations, single-gene status Morphology (how the embryo looks): grade of inner cell mass, trophectoderm, expansion stage Where it fits: You use embryo prioritization after retrieval, not […]
Known vs Agency‑Matched Carriers — Risks and Guardrails
A known carrier is someone you already have a relationship with—sister, cousin, friend, coworker, or someone referred through your network.An agency-matched carrier is screened, vetted, and paired with you through a licensed surrogacy agency. This decision shapes legal exposure, communication patterns, medical approvals, insurance strategy, and total timelines. It’s one of the earliest choices upstream […]
Matching Criteria — Phenotype, Education, and Values
Choosing the right egg donor is one of the most important steps in the Egg Donation 101 pathway. The process involves more than just medical compatibility—it’s about aligning phenotype, education, and personal values to ensure that intended parents feel emotionally and ethically confident about their choice. This article explores how each matching criterion works, who […]
ERA, EMMA, ALICE — When (and When Not) to Use Them
In the journey of fertility testing and assisted reproduction, many tools and diagnostics are available—and among the more advanced and increasingly discussed are ERA, EMMA, and ALICE. These three tests focus on the uterine environment (particularly the lining, or endometrium) rather than solely on eggs, sperm, or embryos. This article explains ERA, EMMA, and ALICE […]
Telehealth and Remote Monitoring — What Works
This article explains telehealth and remote monitoring — what works within the International Surrogacy & Cross-Border Care pathway. It focuses on the decisions that meaningfully change outcomes, budgets, and timelines, so you can move forward with confidence. What It Is Telehealth and Remote Monitoring — What Works, in plain English:Where remote consultations, virtual coordination, and […]
Access and Wait Times — Hidden Friction
Access and wait times are often the “hidden friction” inside the Clinic Selection & Success Rates pathway. This article breaks down how scheduling delays, bottlenecks, and clinic capacity influence real outcomes, budgets, and timelines—so you can make decisions that actually move you forward with confidence. What It Is Access and Wait Times — Hidden Friction […]
Embryo Mosaicism — Decision‑Making Framework
Mosaicism means an embryo has a mix of normal (euploid) and abnormal (aneuploid) cells. It is not fully normal, not fully abnormal—it’s in the middle. Where it fits: Mosaicism is identified through PGT-A. It becomes relevant when you have few or no euploid embryos. It is a transfer decision, not a stimulation decision. What it […]
